Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany

INTRODUCTION: The effectiveness and safety of romiplostim were evaluated by immune thrombocytopenia (ITP) phase (newly diagnosed/persistent/chronic) at romiplostim initiation. METHODS: This is a post hoc analysis of a prospective, German, multicentre, observational study in adults with ITP who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiser, Marcel, Josten, Klaus M., Dietzfelbinger, Hermann, Seesaghur, Anouchka, Schill, Markus, Hippenmeyer, Jane, Welslau, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393823/
https://www.ncbi.nlm.nih.gov/pubmed/34959233
http://dx.doi.org/10.1159/000521689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393823/
https://www.ncbi.nlm.nih.gov/pubmed/34959233
http://dx.doi.org/10.1159/000521689

Ejemplares similares